SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-000339
Filing Date
2024-01-03
Accepted
2024-01-03 17:30:14
Documents
14
Period of Report
2023-12-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38188
2 ex10-1.htm EX-10.1 61269
3 form8-k_001.jpg GRAPHIC 22272
  Complete submission text file 0001493152-24-000339.txt   331942

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE end-20231229.xsd EX-101.SCH 3012
5 XBRL LABEL FILE end-20231229_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE end-20231229_pre.xml EX-101.PRE 22358
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 2926
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55453 | Film No.: 24508315
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)